labor analgesia
Conditions
Interventions
R group:0.167% ropivacaine for labor analgesia
SR group:0.1% ropivacaine in combination with 0.5µg/ml sufentanil for labor analgesia
Sponsors
Obstetrics and Gynaecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Medical records were retrospectively reviewed from May 2018 to June 2020, singleton full-term pregnancy women who received epidural labor analgesia via vaginal delivery were included in the study.
Exclusion criteria
Exclusion criteria: Women with severe systemic disease that results in functional impairment (American Standards Association, ASA>=III) or fetal dysplasia were excluded from the cohort.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| the incidence of episiotomy, instrumental delivery, caesarean section and grade III meconium-stained amniotic fluid; | — |
Primary
| Measure | Time frame |
|---|---|
| labor progress;the incidence of maternal fever, intrapartum hemorrhage, fetal distress and neonatal Apgar scores less than 7 at 1 and 5 minutes; | — |
Countries
China
Contacts
Public ContactYue Li
Obstetrics and Gynaecology Hospital of Fudan University
Outcome results
None listed